Source Adapted from Gusmano et al. (2006) Variable Rationale Data descriptions 1. Older population size The degree of frailty increases with age, thereby leading to physical and cognitive decline and limited competence [that is, physical and mental health, intellectual capacity or ego strength (Lawton 1977)].
Based on this rationale, data from yeast two hybrid methods are sufficiently consistent to allow for intra species comparisons (between different experiments) and inter species comparisons, while data from affinity purification mass spectrometry methods show large differences even within intra species comparisons.
The present article summarizes the rationale, clinical data, devices, implantation techniques and follow-up drug regimens.
This chapter provides a description of the different components of the Research Training Plan, including Significance, Rationale, Preliminary Data, Experimental Design, Expected Results, and Potential Problems and Alternatives.
3. Ending sugar and junk food marketing to children The rationale and data behind this are clear.
Despite this rationale, the data in this study at the 400 mg b.i.d.
The selected hypothesis should be the one best supported by the scientific rationale and data to that point.
This is consistent with scientific rationale and data regarding glucocorticoid use in sepsis at other anatomical sites.
This review summarizes the rationale, clinical data, and the results from contemporary studies, as well as exploring the future role of bevacizumab in RCC therapy.
In regard to the therapeutic use of vitamins C and E with purposes of cardioprotection, although the scientific rationale, epidemiologic data, and retrospective studies have been persuasive, prospective, randomized, placebo-controlled trials have not verified their actual benefit in human diseases [ 140].
However, the analyses relate to one secondary efficacy outcome (relative risk of ≥ 10 letter gain at 12 months), not the primary efficacy outcome in any pivotal phase III study of IVR or IVT-AFL (mean gain in BCVA at 12 months in VIVID-DME/VISTA-DME), and there was a lack of detail on the rationale for data inclusion and extraction, assessment of bias and statistical methods used for adjustment.
